Expression of IL-4, Cε RNA, and lε RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids

Journal of Allergy and Clinical Immunology

Volumn 101, Issue 3, 1998, Pages 330-336

  Cameron, Lisa A ^a   Durham, Stephen R ^b   Jacobson, Mikila R ^c   Masuyama, Keisuke ^d   Juliusson, Sigurdur ^a   Gould, Hannah J ^a   Lowhagen, Olle ^b   Minshall, Eleanor M ^c   Hamid, Qutayba A ^d  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allergic rhinitis; C , I ; IgE; IL 4; Topical corticosteroids

Indexed keywords

FLUTICASONE PROPIONATE; IMMUNOGLOBULIN E; INTERLEUKIN 4;

ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; HUMAN TISSUE; NOSE MUCOSA; POLLEN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

EID: 0031953750     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(98)70244-1     Document Type: Article

References (35)

1. Vamey VA, Jacobson MR, Sudderick RM, Robinson DS, Irani AMA, Schwartz LB, et al. Immunohistology of the nasal mucosa after allergen-induced rhinitis: identification of activated T lymphocytes, eosinophils and neutrophils. Am Rev Respir Dis 1992; 146:170-6.
2. Durham SR, Ying S, Vamey VA, Jacobson M, Sudderick RM, MacKay IS, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and GM-CSF in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148:2390-4.
3. Abehsira-Amar O, Gibert M, Joliy M, Theze J, Jankovic DL. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J Immunol 1992;148:3820-9.
4. Del Prete GF, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, et al. IL-4 is an essential factor for the synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140: 4193-8.
5. Rousset F, Robert J, Andary M, Bonnin JP, Souillet G, Chrétien I, et al. Shifts in IL-4 and IFN-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 1991;87:58-69.
6. Gauchet JF, Lebman DA, Coffman RL, Hugues G, Vries JE. Structure and expression on germline e transcripts in human B cells induced by interleukin-4 to switch to IgE production. J Exp Med 1990;172:463-73.
7. Rothman P, Chen YY, Lutzker S, Li SC, Stewart V, Coffman R, et al. Structure and expression of germ line immunoglobulin heavychain e transcripts: interleukin-4 plus lipopolysaccharide-directed switching to Ce. Mol Cell Biol 1990;10:1672-9.
8. Stavnezer-Nordgren J, Siftin S. Specificity of immunoglobulin heavy chain switch correlates with activity of germline heavy chain genes prior to switching. EMBO J 1986;5:95-102.
9. Lutzker S, Rothman R, Pollock R, Coffman T, Alt F. Mitogen and IL-4 regulated expression of germline Ig-γ2b transcripts: evidence for directed heavy chain class switching. Cell 1988;53:77-80.
10. Stavnezer J, Radcliffe G, Lin YC, Nietupski J, Berggren L, Sitia R, et al. Immunoglobulin heavy chain switching may be directed by prior induction of transcripts from constant region genes. Proc Natl Acad Sci U S A 1988;85:7704-10.
11. Yancopoulos GD, Alt FW. Regulation of the assembly and expression of variable region genes. Annu Rev Immunol 1986;4:339-45.
12. Gillon J. Where do mucosal mast cells acquire IgE? Immunol Today 1981;2:80-1.
13. Merrett TG, Houri M, Mayer ALA, Merrett J. Measurement of specific IgE antibodies in nasal secretions: evidence for local production. Clin Allergy 1976;6:69-73.
14. Illium P, Balle V. Immunoglobulins in nasal secretions and nasal mucosa in perennial rhinitis. Acta Otolaryngol 1978;86:135-41.
15. Durham SR, Gould HJ, Hamid QA. Local IgE production in nasal allergy. Int Arch Allergy Immunol 1997;113:128-30.
16. Rak S, Jacobson MR, Sudderick RM, Masuyama K, Juliusson S, Kay AB, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994;24:930-9.
17. Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick M, Kay AB, et al. Topical glucocorticoid (fluticasone propionate) inhibits cells expressing cytokine messenger RNA IL-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994;82:192-9.
18. Durham SR, Gould HJ, Thienes CP, Jacobson M, Masuyama K, Rak S, et al. Expression of c-gene transcripts and mRNA for the c heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol 1997;27:2899-906.
19. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ 1991;302:265-9.
20. Kay AB, Ying S, Vamey VA, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5 and granulocyte/macrophage colony-stimulating factor, in allergen induced late-phase cutaneous reactions in atopic subjects. J Exp Med 1991;173:775-80.
21. Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic rhinitis patients with negative skin tests. Lancet 1975;2: 148-50.
22. Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol 1979;122:2218-25.
23. Naclerio RM, Adkinson NF, Creticos PS, Baroody FM, Hamilton RG, Norman PS. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol 1993;92:717-21.
24. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge: effect of corticosteroid pre-treatment. Am Rev Respir Dis 1988;138:406-12.
25. Yunginger JW, Gleich GJ. Seasonal changes in serum and nasal IgE concentrations. J Allergy Clin Immunol 1973;51:174-86.
26. Chvatchko Y, Kosco-Vilbois MH, Herren S, Lefort J, Bonnefoy JY. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J Exp Med 1996;184:2353-60.
27. Robinson D, Hamid Q, Ying S, Bentley A, Assoufi B, Durham S, Kay AB. Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-γ cytokine gene expression. Am Rev Respir Dis 1993;148:401-6.
28. + cells in the nasal mucosa. J Allergy Clin Immunol 1995:95:300.
29. Wu CY, Sarfati M, Heusser C, Foumier S, Rubio-Trujillo M, Peleman R, et al. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1991:87:870-7.
30. Kimata H, Lindley I, Furusho K. Effect of hydrocortisone on spontaneous IgE and IgG4 production in atopic patients. J Immunol 1995:154:3557-66.
31. Gross A, Ben-Sasson SZ, Paul WE. Anti-IL-4 diminishes in vivo priming for antigen-specific IL-4 production by T cells. J Immunol 1993:150:2112-20.
32. Kruse N, Tony HP, Sebald W. Conversion of human IL-4 into a high affinity antagonist by a single amino acid replacement. EMBO J 1992;11:3237-44.
33. Gessner A, Schroppel K, Will A, Enssle KH, Lauffer L, Rollinghoff M. Recombinant soluble IL-4 receptor acts as an antagonist of IL-4 in murine cutaneous Leishmanias. Infect Immun 1994;62:411-7.
34. Noelle RJ, Roy M, Shepard DM, Stamenkovic I, Ledbetter JA, Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc Natl Acad Sei U S A 1992;89:6550-4.
35. Nonoyama S, Hollenbaugh D, Aruffo A, Ledbetter JA, Ochs HD. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J Exp Med 1993;178:1097-102.